Landmark year ahead for colorectal cancer testing and liquid biopsies (Medical Device Network)

March is National Colorectal Cancer (CRC) Awareness Month, a time aimed at raising awareness for what is the world’s second leading cause of cancer death worldwide. With pivotal clinical trials for new cancer blood tests – so-called ‘liquid biopsies’ – occurring in 2022, transformative change for the diagnostics surrounding CRC may be around the corner. Key developments in the CRC space have the potential to shape the rapidly evolving market around liquid biopsies.